Skip to content
BirlesaBirlesa
Ask or searchSign in
Menu

Product export scorecard · GTİP 3002Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera,…Official Turkish text: İnsan kanı, tedavi/korunma/teşhis için hayvan kanı, antiserum vb., bağışıklık sağlayan ürünler, aşı, toksin, mikroorganizma/hücre kültürleri, vb. ür.

Its biggest market for the heading is South Korea: €346m in the 12 months to August 2026 (+40.3% on the year before). In Saudi Arabia, Türkiye's share is 0%: US$203k in the 12 months to April 2026.

From official statistics and the tenders on Birlesa, each with its source and date; refreshed as new tenders arrive.

News for this product

New tenders and purchase requests, Türkiye's new duties, duties and recalls abroad, new requirements and buying signals: by e-mail, with a free account.

Follow this product

Ready to sell it?

Birlesa's team prepares an offer for the buyers of this code with you.

Prepare an offer for me

Nothing goes to a buyer without your approval.

↵ select↑↓ moveesc close